Сell-free pertussis vaccine from antigens of freshly isolated strain of B. pertussis serotype 1.2.3

Aim. Development of technology for the manufacture of cell-free pertussis vaccine (CPV) from a freshly isolated strain of B. pertussis No. 211 serotype 1.2.3 and the study of its protective activity and safety in comparison with the preparation of vaccine strains. Materials and methods. Following B....

Full description

Bibliographic Details
Main Authors: Evgeniy M. Zaitsev, Irina G. Bazhanova, Marina V. Britsina, Natalia U. Mertsalova, Mariya N. Ozeretskovskaya
Format: Article
Language:Russian
Published: Central Research Institute for Epidemiology 2020-05-01
Series: Журнал микробиологии, эпидемиологии и иммунобиологии
Subjects:
Online Access:https://microbiol.elpub.ru/jour/article/view/776